Skip to main content
Download PDF

Ziziphi spinosae lily powder suspension in the treatment of depression-like behaviors in rats

BMC Complementary and Alternative Medicine volume 17, Article number: 238 (2017) Cite this article

Abstract

Background

Depression is a chronic, recurring and potentially life-threatening illness. Current treatments for depression are characterized by a low success rate and associated with a wide variety of side effects. The aim of the present study was to evaluate the behavioral anti-depressant effect of a novel herbal compounds named ziziphi spinosae lily powder suspension, as well as to investigate its potential mechanisms.

Methods

Except for body weight, depressive-like behaviors were also evaluated using forced swimming test, sucrose consumption test and open field test. In order to investigate the underlying potential mechanisms, serum 5-HT and brain 5-HIAA were measured using ultrahigh-performance liquid chromatography and high-performance liquid chromatography, respectively.

Results

Results showed that the herbal compounds ziziphi spinosae lily suspension could alleviate depressive symptoms in rat model of chronic depression. Biochemical analysis revealed that the herbal compounds elevated serum 5-HT and brain 5-HIAA.

Conclusion

Ziziphi spinosae lily powder suspension could alleviate depressive behaviors in depression model animals. The underlying mechanisms may be related to the increase of serum 5-HT in peripheral blood and 5-HIAA in brain. The study provides important mechanistic insights into the protective effect of the herbal compounds against chronic depressive disorder and suggests that the herbal compounds may be a potential pharmacological agent for treatment of major depressive disorder.

Peer Review reports

Background

Major depression is a chronic and recurring neuropsychiatric disorder which is characterized by persistent depression in spirits, retardation of thinking and decrease of interest. It is a highly prevalent disease with high disability and mortality rates [1]. Pharmacotherapy of the disorder has evolved over centuries. Western medicine, such as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressant (TCA), and monoamine oxidase (MAO) inhibitors, used to treat depression aims to moderate brain neurotransmitters involved in the pathogenesis of the disease and has made indelible contributions. However, complaints such as narrow spectrum, undesirable side effects, limited response, high price and easy recurrence are often reported during the course of treatment [2]. So, there is an urgent need for researchers to investigate more effective antidepressant therapies without any or with less adverse effects.

Chinese herbal medicine is one of the most commonly used modalities of alternative medicine therapy [3]. A handful of researches have suggested that herbal medicines show promise in managing mild to moderate depression [4, 5]. Various Chinese herbal formulas are widely used to prevent or relieve mental depression among the populace [6]. Semen ziziphi spinosae is the dried seed of Zizyphus jujube Mill var.spinosa (Rhamnaceae). The major active compounds in semen ziziphi spinosae include jujuboside, spinosin, alkaloids, flavonoids, fatty oils, rutin and so on [7, 8]. Majority of them exert a number of pharmacological effects including antihyperlipidemia, immunopotentiation, and anxiolytic effects [9]. For example, jujuboside A and spinosin exhibit excellent neuroprotective effects, such as ameliorating learning and memory performance in mice [10, 11], alleviating sleep disorder in rats and mice [12, 13], and inhibiting hyperactivity of mice [14,15,16]. Antidepressant-like effect of the extract from Sunzaorenhehuan Formula was also confirmed in mice model of depression [17]. So, Semen ziziphi spinosae is used widely in China, Japan, Korea and other oriental countries, prescribed as a monarch drug for patients with sleep disorder, anxiety, nervous exhaustion, night sweats and so on [13, 18]. Fufang Suanzaoren decoction, a traditional Chinese medicine preparation, has been used widely for treating anxiety and insomnia in clinical practice [19]. Lily is widely grown in China for ornamental, medicinal and dietary purpose. Lily bulb showed protective effect for digestive system including attenuation of colitis in rats [20], hepatoprotective activities in mice [21]. There is also a long history using lily bulb to treat depression. In medicine book JinKui YaoLue wroted by Zhang Zhongjing major depressive disorder was named as BaiHe disease since lily bulb was the main herbal medicine to treat it. Li Shizhen also pointed out in his book Ben cao gang mu (Compendium of Materia Medica) that lily bulb had sedative effect for depressive disorder patients [22]. Extract of lily bulb selected from ethno botanical survey was reported to inhibit MAO in rats, similar to the effect of antidepressant MAO inhibitors [23, 24]. A new herbal treatment composed of lily bulb exhibited anxiolytic and antidepressant-like effects in mice [24,25,26].

Though both the materials have a long history as anti-depressive medicines, they are usually combined with several other herbs respectively. Since both of them are medicinal and edible materials, it is a useful attempt to combine the two materials to investigate the total anti-depressive effect in order to maximize the efficacy and minimize the adverse effects. In present study, the ziziphi spinosae lily powder suspension made of semen ziziphi spinosae and lily bulb was used to investigate the antidepressant effect on depressive model rats. Additionally, in order to elucidate the possible underlying mechanisms, a quantitative analysis of serum serotonin (5-HT) in peripheral blood and brain 5-hydroxyindoleacetic acid (5-HIAA) were performed using ultrahigh-performance liquid chromatography (UPLC) and high-performance liquid chromatography (HPLC), respectively.

Methods

Animals

Thirty male Sprague - Dawley rats (200–250 g) were obtained from the Department of Laboratory Animal Science, Anhui Medical University (Hefei, China). The animals were housed individually under standard colony conditions, with a 12 h light/dark cycle and ad libitum food and water. They were allowed to acclimatize to the colony for at least 7 days before any experimentation. All experimental manipulations were carried out during the light phase of the light/dark cycle.

Animal model

Animal model of depressive disorder was used to assess the antidepressant effect of ziziphi spinosae lily powder suspension in rats. The chronic depressive disorder model was induced by chronic unpredictable mild stress (CUMS). The experimental protocol is shown in Fig. 1. Here, pre-CUMS is defined as the parameters measured before modeling (CUMS) and post-CUMS is defined as the parameters observed after modeling.

Fig. 1
figure 1

Overall flow of the experimental design. △: The assessment of depressive-like behaviors at different time points; ▲: The detection of body weight at different time points

Full size image

Stressors were administered once daily between 08:30 and 10:30, with the exception of the 24-h duration stressors. The CUMS procedure was revised from the reference [27]. Stressors consisted of (1) 5-min warm swim at 42 °C; (2) 24-h wet litter; (3) 24-h food deprivation; (4) 90-s tail pinch; (5) 24-h water deprivation; (6) 5-min cold swim at 4 °C, after which they were toweled dry; (7) 24-h cage tilt (cages were tilted to 45° from the horizontal). The stressors were distributed randomly with intervals of at least 7 days. All stressors were administered four times within 4 weeks.

At last, 6 rats were excluded from the experiment because of intolerance or insensitive to the CUMS procedure. Then all animals were randomized into three groups with 8 rats per group: the fluoxetine group, the lily jujube group and the control (untreated) group.

Pharmacological treatment

All drugs were orally administered. For the fluoxetine group, the animals were administered a daily oral dose (10 mg/kg/d, diluted in distilled water) of the SSRI fluoxetine (Eli Lilly & Co., Souzhou, China) on each morning. For the lily jujube group, both the crude drugs were purchased from Anhui Traditional Chinese medicine pharmacy and were mixed at a ratio of 1:1. The even mixture of dried lily bulb and semen ziziphi spinosae was homogenized to a fine powder. 10% ziziphi spinosae lily powder suspension was prepared by adding the powder into distilled water. In the clinical practice of Chinese pharmacopoeia, the dried lily bulb is usually prescribed at a daily dose of 6–12 g and semen ziziphi spinosae is prescribed at 9–15 g. Considering the combination of the two materials, we selected equivalent drugs to mix. The dose for human being was converted into a rat dose (a person of 60 kg, and a conversion factor of 6.17 between human and rat according to total body surface area). The ultimate dose administered to rats was 2 ml 10% ziziphi spinosae lily powder suspension (100 mg/Kg/d). Rats in the control group received equivalent distilled water.

Body weight (BW)

Effect of the stress and treatment on BW was measured by an electronic balance. Change of BW was recorded at fixed time points.

Behavioral assessments

Forced swimming test (FST), sucrose consumption test (SCT) and open field test (OFT) were performed. Changes in these parameters reflected the behavioral characteristic phenotypes of depression in rats.

Forced swimming test (FST)

FST is a procedure in which rats are forced to swim for 6 min. This parameter was performed as described previously [28]. The rat was placed individually in a Plexiglas cylinder 50 cm tall, 20 cm diameter filled to 40 ± 1.5 cm with 24 ± 0.5 °C water from which escape was impossible. Fifteen minutes later, the rat was removed and dried before being returned to its home cage. Fresh water was used for each rat and the cylinder was also cleaned between trials. After 24 h, the animals were returned to the cylinders and the procedure was repeated for another 6 min. Immobility time, swimming time and climbing time were recorded for 2–6 min by video camera through the side of the cylinder, which was illuminated from the opposite side. An experimenter monitored the video camera unaware of the treatment received by the animals. Immobility was defined as the lack of motion of the whole body, except for small movements necessary to keep the animal’s head above the water. This indicates learned helpless and is one of the core diagnostic criteria, increasing with the severity of the condition.

Sucrose consumption test (SCT)

SCT was described by Papp et al. as a measure of hedonic behavior [29]. It is one of the core diagnostic criteria for depressive disorder with a decrease in the volume of sucrose consumed indicating a depressed state named ahedonia. Sucrose intake was introduced at weekly intervals during the CUMS procedure. After a 24-h period of water deprivation, SCT was performed in the home cage. Animals were given a 1% sucrose solution and after 24 h, the consumption of sucrose was measured by weighing the bottles.

Open field test (OFT)

Open field test was used as a standard test for assessment of spontaneous locomotor activity, explorative activity and anxiety in rodents. The animals were submitted to the open field paradigm as previously described [30]. For the performance of the test, an apparatus (100 × 100 × 40 cm) was bordered by opaque high walls. All parts of the bottom were divided into 16 squares. During the experiment, all parts of the room except for the open field were kept dark. The apparatus was illuminated by a 100 W bulb focused on the field from a height of about 110 cm from the ground. For assessment of the activities, each animal was centrally positioned in the field for a maximum of 5 min to monitor the following behaviors: crossing: the number of squares crossed by the mice; rearing: frequency with which the rat stood on their hind legs during the test of 5 min; number of fecal: fecal granule produced by the mice during the period. The box was cleaned with a detergent and dried after occupancy by each mouse. All the experiments were done by two operators, who were unaware of the treatment received by the animals.

Measurement of serum 5-HT and cerebral 5-HIAA

To explore the detailed neurochemical mechanisms involved in the antidepressant-like effect of the ziziphi spinosae lily powder suspension, mice receiving treatment for 4w were used for the determinations of serum 5-HT and cerebral 5-HIAA (The metabolite of 5-HT) levels. Rats were deeply anesthetized with chloral hydrate. 2 ml peripheral blood was obtained from the rat tail veins. After stewing for 10mins, the blood was then centrifuged at 3000rmp for 10 min at 4 °C. The supernatants were kept at -80 °C until quantification of serum 5-HT were performed. Then rats were sacrificed by decapitation. Their brains were rapidly removed from the skull. The blood vessels and the soft cerebral covering were removed carefully from the brain before being frozen on dry ice. They were then weighed, homogenized with an Ultrasonic Turax T25 (Bio-block Scientific, France) in 1 × PBS (10mlPBS/g brain tissue). They were centrifuged at 10000rmp for10 min at 4 °C. The supernatants were kept at -80 °C until quantification of 5-HIAA and the total soluble protein were performed.

5-HT (Sigma) was determined by UPLC with fluorescence detection (Waters Acquity UPLC BEH C18 1.7um, American) according to a previously described procedure [31]. The UPLC equipment includes a Waters automatic sampler equipped with a Waters fluorescence detector, an Acquity UPLC BEH C18 column (2.1 × 100 mm, Waters) and a pre-column (Acquity BEH C18). The data were acquired and processed by data processing system (Empower).

The supernatant samples were deproteinized by mixing with an equal volume of 5% (V/V) perchloric acid, followed by vortex- mixing and centrifuged at 14000r for 10 min at 4 °C. The chromatographic separation for 5-HT was carried out using the mobile phase consisting of 0.1 mol/l KH2PO4 and methanol (80:20, V/V; pH = 4.3), at a flow rate of 0.3 ml/min. The mobile phase was filtered with 0.22um filter membrane and was degassed in an ultrasonic bath before measurement. The injection volume was 5 μl. The excitation wavelength was 278 nm and the emission wavelength was 338 nm (See Additional file 1: Figure S1.). Linear equation, linear range and detection limit of 5-HT were as follows (See Table 1).

Table 1 Linear equations, linear ranges and detection limits of 5-HT and 5-HIAA
Full size table

5-HIAA (Sigma) was measured as described previously using high-performance liquid chromatography (HPLC, Agilent 1260) with electrochemical detection (Antec, Decade sdc) with minor modifications [32]. The supernatant was analyzed by HPLC using an Agilent C18 column (5 um, 4.6 mm × 250 mm, USA). The supernatant samples were deproteinized by mixing with an equal volume of 5% (V/V) perchloric acid, followed by vortex- mixing and centrifuged at 14000r for 10 min at 4 °C. The chromatographic separation for 5-HIAA was carried out using 2000 ml mobile phase consisting of 20.7 g NaH2PO4, 0.735 g Octanesulfonic Acid Sodium, 200 ml acetonitrile, 200ul triethylamine, 25umol EDTA at a flow rate of 1 ml/min (PH = 3.8). The mobile phase was filtered with 0.22um filter membrane and was degassed on line before measurement. The injection volume was 20 μl by a manual sampler. Chromatogram of 5-HIAA under optimal conditions were shown in Additional file 2: Figure S2. Linear equation, linear range and detection limit of 5-HIAA were as follows (See Table 1).

The total soluble protein in brain supernatants was considered as the internal reference standard of 5-HIAA. It was detected by improved concentration BCA protein assay kits (Sangon Biotech, Shanghai co., Ltd).

Data analysis

Data were expressed as the mean ± S.E.M (standard error of the mean). Data were analyzed using Spss11.5 software using repeated measures of analysis of variance (ANOVA) by post-hoc test for the parameters within the same group and one-way ANOVA followed by least significant difference test for the parameters among the different groups (two-tailed). In all instance, P < 0.05 was considered statistically significant.

Results

BW

Body weight of rats was increased obviously according with time [F (2, 22) =60.756, P < 0.01]; Time and group interaction factors (time*groups) were obviously significant [F (2, 22) =14.339, P < 0.01]. There were also obvious significance among groups [F (2, 22) =7.705, P = 0.003]. During the whole procedure including stress conditions and treatment period, body weight of three groups was growing all the time [F (2, 22) =46.717, P < 0.01; F (2, 22) =23.780, P < 0.01; F (2, 22) =62.456, P < 0.01, respectively]. When compared with the control group, body weight of post-treatment in the lily jujube group was significantly increased whereas it was increased without significance in the fluoxetine group [F(2,22) = 2.278, P = 0.045; F(2,22) = 2.278, P = 0.331, respectively] (See Fig. 2).

Fig. 2
figure 2

Changes of body weight at different time points. Note: # < 0.05 compared within group with post-CUMS; ^< 0.05 compared with the control group

Full size image

FST

Immobility time, swimming time and climbing time were homogeneous among pre-model animals by one-way ANOVA [F (2, 22) =1.016, P = 0.379; F (2, 22) =0.62, P = 0.548; F (2, 22) =0.418, P = 0.664, respectively]. During the whole procedure, three indexes in the FST were changed obviously according with time [F (2, 22) =19.228, P < 0.01; F (2, 22) =16.045, P < 0.01; F (2, 22) =25.766, P < 0.01, respectively]; Time and group interaction factors (time*groups) for immobility time and swimming time were significant while that of climbing time was not significant [F (2, 22) =3.807, P = 0.01; F (2, 22) =3.485, P = 0.017; F (2, 22) =1.031, P = 0.386, respectively]. After the CUMS procedure, immobility time, swimming time and climbing time were noticeably changed in model rats by pared-samples T test (t = -4.652, P < 0.05; t = -4.745, P < 0.05; t = 6.443, P < 0.05). Following antidepressant treatment for 4w, immobility time in the lily jujube group and fluoxetine group was significantly decreased [F (2, 22) =35.135, P < 0.01; F (2, 22) =7.090, P = 0.025, respectively]; swimming time in the two groups was significantly increased [F (2, 22) =48.107, P < 0.01; F (2, 22) =14.914, P = 0.025, respectively]; climbing time in the two groups was not significantly improved [F (2, 22) =41.659, P = 0.661; F (2, 22) =11.709, P = 0.991, respectively]. However, in the control group, no similar effect was found. After treatment for 4w, comparison of three indexes with the control group showed: immobility time in both the lily jujube group and the fluoxetine group was significantly decreased [F(2,22) = 10.266, P < 0.01; F(2,22) = 10.266, P < 0.01, respectively]; swimming time in both the lily jujube group and fluoxetine group was increased obviously [F(2,22) = 12.301, P <0.01; F(2,22) = 12.301, P <0.01, respectively]; climbing time in the two groups was also significantly different [F(2,22) = 5.929, P < 0.01; F(2,22) = 5.929, P <0.01, respectively] (See Fig. 3).

Fig. 3
figure 3

Changes of immobility time, swimming time and climbing time in FST at different time points. a: Immobility time of FST; b: Swimming time of FST; c: Climbing time of FST. Note: *< 0.05 compared within group with pre-CUMS; # < 0.05 compared within group with post-CUMS; ## < 0.01 compared within group with post-CUMS; ^^<0.01 compared with the control group

Full size image

SCT

Before modeling, sucrose consumption was similar among the groups [F (2, 22) =0.105, P = 0.901]. During the whole procedure, the sucrose consumption was changed obviously according with the time [F (2, 22) =30.875, P < 0.01]; Time and group interaction factors (time*groups) were obviously significant [F (2, 22) =7.769, P < 0.01]. CUMS procedure significantly decreased sucrose consumption compared by pared-samples T test (t = 7.235, P < 0.01). Treatment with the ziziphi spinosae lily powder suspension and fluoxetine remarkably alleviated the decrease in sucrose consumption in CUMS model animals [F (2, 22) =20.311, P < 0.01; F (2, 22) =14.763, P < 0.01, respectively]. However, in the control group, no similar effect was found. When compared with the control group, sucrose consumption of post-treatment in both the lily jujube group and the fluoxetine group was significantly increased [F(2,22) = 14.451, P < 0.01; F(2,22) = 14.451, P < 0.01, respectively] (See Fig. 4).

Fig. 4
figure 4

Changes of sucrose consumption in SCT at different time points. Note: *< 0.05compared within group with pre-CUMS; **< 0.01 compared with the pre-CUMS within the group; ## < 0.01 compared within group with post-CUMS; ^<0.05 compared with the control group

Full size image

OFT

Before modeling, the number of rearing, crossing and fecal granule was similar among the groups [F (2, 22) =0.607, P = 0.554; F (2, 22) =0.439, P = 0.650; F (2, 22) =2.063, P = 0.153, respectively].

Rearing movement during the whole procedure was changed obviously according with time [F (2, 22) =10.848, P < 0.01]. Time and group interaction factors (time*groups) were not obviously significant [F (2, 22) =3.24, P = 0.21]. CUMS procedure decreased rearing movement significantly (t = 3.733, P < 0.01). Treatment with the ziziphi spinosae lily powder suspension remarkably alleviated the decrease in rearing movement in CUMS model animals [F (2, 22) =4.787, P = 0.042]. However, in the fluoxetine group and control group, no similar effect was found [F (2, 22) =2.977, P = 0.349; F (2, 22) =19.562, P = 1]. When compared with the control group, rearing movement of post-treatment in the lily jujube group was significantly increased whereas it was not obviously increased in the fluoxetine group [F(2,22) = 5.583, P < 0.01; F(2,22) = 5.583, P = 0.51, respectively] (See Fig. 5).

Fig. 5
figure 5

Changes of parameters in OFT at different time points. a: Number of crossings; b: Number of rearings; c: Number of fecal granule. Note: *< 0.05 compared within group with pre-CUMS; **< 0.01 compared with the pre-CUMS within the group; # < 0.05 compared within group with post-CUMS; ## < 0.01 compared within group with post-CUMS; ^^<0.01 compared with the control group

Full size image

Crossing movement during the whole procedure was also changed obviously according with time [F (2, 22) =18.143, P < 0.01]. But, time and group interaction factors (time*groups) were not obviously significant [F (2, 22) =0.536, P = 0.71]. CUMS procedure decreased crossing movement significantly (t = 3.913, P < 0.01). However, none of the groups was obviously elevated after the treatment procedure (See Fig. 5). When compared with the control group, crossing movement of post-treatment in both the lily jujube group and the fluoxetine group was increased without significance [F(2,22) = 2.092, P = 0.06; F(2,22) = 2.092, P = 0.228, respectively] (See Fig. 5).

The number of fecal granule during the whole procedure was changed obviously according with time [F (2, 22) =10.691, P < 0.01]. Time and group interaction factors (time*groups) were obviously significant [F (2, 22) =6.347, P < 0.01]. CUMS procedure increased the number of fecal granule significantly compared by pared-samples T test (t = -4.227, P < 0.05). Treatment with the ziziphi spinosae lily powder suspension and fluoxetine remarkably alleviated the increase of fecal granule in CUMS model animals [F (2, 22) =13.532, P = 0.048; F (2, 22) =9.488, P < 0.01, respectively]. However, in the control group, no similar effect was found. When compared with the control group, the number of fecal granule of post-treatment in both the lily jujube group and the fluoxetine group was decreased significantly [F(2,22) = 14.413, P P < 0.01; F(2,22) =14.413, P P < 0.01, respectively] (See Fig. 5).

Serum 5-HT and brain 5-HIAA

Compared with the control group, serum 5-HT of both the lily jujube group and the fluoxetine group were increased significantly [F (2, 22) =3.356, P = 0.032; F (2, 22) =3.356, P = 0.041, respectively] (See Fig. 6). There was similar result observed with brain 5-HIAA determination in both the lily jujube group and the fluoxetine group [F (2, 22) =3.198, P = 0.042; F (2, 22) =3.198, P = 0.038, respectively].

Fig. 6
figure 6

Measurement of serum 5-HT and brain 5-HIAA after treatment. a: Measurement of serum 5-HT; b: Measurement of 5-HIAA/Pr (×10-3) of brain tissue homogenate. Note: The presented data are mean + S.E.M. Statistical analysis was carried out by one way ANOVA. *< 0.05 compared with the control group

Full size image

Discussion

Depression has become a worldwide problem. Although many antidepressant drugs have been developed, treatments with those drugs are not always satisfactory [33, 34]. Alternative approaches with fewer adverse effects are often sought [35]. In Chinese culture, herbal medicine is one of the most commonly used antidepressant therapies to treat mild to moderate depression. Studies have shown therapeutic potential of chronic treatment with several herbal medicines, such as St. John's Wort, jujuboside, Lily bulb, Crocus sativus and Fructus zizyphi jujubae, Chaihu-Shugan-San, Xiao-Yao-San and so on [36,37,38,39,40,41]. Chronic treatment with such herbal medicines was shown to have antidepressant-like effect, to normalize brain transmitter levels [42], similar to the effect seen following SSRI treatment. On the basis of the antidepressant experience of Chinese medicine, we selected two kinds of medicinal and edible materials, dried lily bulb and semen ziziphi spinosae, to investigate the total anti-depressive effect and the possible underlying mechanisms.

In order to induce the depression-like behaviors in human, several animal models have been developed. Among them, CUMS procedure is a classic method for inducing depressive disorder in animals since it mimics the stressful events common in human society. The validity of CUMS procedure has been demonstrated in previously published reports [43]. In our study, after 4w of CUMS procedure, the animals showed slow body weight gain and increased behavioral obstacles evaluated by FST, SCT and OFT, which indicated that the model was successful in mimicking the core depression symptoms, such as anhedonia, obtained helpless, declined athletic activity, reduced curiosity and anxiety.

Our data showed that the body weight of all groups was increased during chronic treatment with increase in the lily jujube group being the largest. Even so, we need to be cautious in interpreting this as a sign of improvement, because both semen ziziphi spinosae and lily bulb are dietary food that may stimulate the appetite of rats. Lily bulb even benefited the animals with potential enteritis [20].

FST is one of the most common predictive tests for screening of antidepressant-like activity drugs. Immobility time in the FST is an index of behavioral despair and antidepressant drugs are able to reduce the time spent in this posture [44, 45]. Its predictive validity is so high that if a treatment reduces immobility time, it suggests that it has an antidepressant effect [45]. Moreover, other behavioral changes in FST indicate the potential mechanisms since the effects of selective serotonin reuptake inhibitors reduce immobility and increase swimming behavior while selective norepinephrine reuptake inhibitors reduce immobility and increase climbing behavior [46]. Another essential parameter is consumption of sucrose in the SCT. A lower level of sucrose consumption or sucrose preference in stressed animals has been interpreted as a marker of anhedonia, which is a core symptom of depression when interest in pleasurable and rewarding experiences is lost [47]. In present study, after administrated ziziphi spinosae lily powder suspension for 4w, the immobility time of the animals was decreased while the swimming time was increased, which agreed with the increased serum 5-HT and brain 5-HIAA, the metabolites of brain 5-HT. The sucrose consumption in the SCT was also reversed to the state before CUMS. All the convincing evidences indicated that the ziziphi spinosae lily powder suspension administrated by oral produced a specific antidepressant-like effect in FST and SCT. The result was in accordance with existing researches about antidepressant effect of semen ziziphi spinosae [17]. The antidepressant effect of Baihe Dihuang Tang whose main contents is lily bulb also involves the elevation of brain 5-HT [24].

OFT is usually used to assist in diagnosis of anxiety, a common symptom involved in depressive disorder [48]. However, it is also used to judge the false positive or negative effect by enhanced or diminished loco motor activity due to psycho-stimulating side effects of the antidepressants in a behavioral despair test [49]. Interestingly, when OFT is used for these two purposes, the results are quite the opposite. The three indexes, crossing movement, rearing movement and the number of fecal granule in the OFT may show loco motor activity, exploratory behavior and anxiety in the strange surroundings, respectively. After CUMS procedure, both the decreased number of activities and the increased number of fecal indicated the depression-like behaviors of CUMS-exposed animals. After treatment for 4w, the number of crossings was not increased obviously which may rule out the possibility that the reduction in the immobility time elicited by the medicine was due to an enhancement in the loco motor activity. On the contrary, the ziziphi spinosae lily powder suspension increased rearing activity obviously while fluoxetine failed. It seems that the ziziphi spinosae lily powder suspension wins out over fluoxetine in resuming their curiosity to the strange surroundings. At last, the decreased fecal in the lily jujube group directly reflected the improvement of anxiety. Changes in all of these indicators suggested that the ziziphi spinosae lily powder suspension ameliorated depressive symptoms of the modal animals.

Monoamine neurotransmitters have been considered to be involved in the etiologies of many disease states, such as depression, anxiety and panic disorder [17, 50]. The dysregulation of the central nervous system involving the neurotransmitters noradrenalin, serotonin and dopamine has been suggested to play an important role in the pathogenesis of depression [51, 52]. Among them, serotonergic system dysfunction is the most widely accepted hypothesis of the biological basis of depression because it is intimately linked to stress and anxiety response [53]. Generally speaking, brain 5-HT is not easily accessible to us in clinical practice. Serum 5-HT level in peripheral blood plays a more important role since it indicates brain 5-HT level indirectly. In our study, after treatment for 4w, we detected the serum 5-HT level by UPLC. And since brain 5-HT is easily degraded when kept for a little long time, the concentration of 5-HIAA, the metabolites of 5-HT, would reflect the level of brain 5-HT. So, except for serum 5-HT, brain 5-HIAA was detected by HPLC. The result showed the ziziphi spinosae lily powder suspension increased both the serum 5-HT and the brain 5-HIAA. This result was in line with the anti-stress effect observed with semen ziziphi spinosae modulating 5-HT activity [37]. The accordance between the elevation of serum 5-HT and the amelioration of depressive behaviors suggests that serum 5-HT may play an important role in both diagnosis of major depressive disorder and judgment of antidepressant effect.

Conclusions

The present study confirmed the antidepressant-like effect of the ziziphi spinosae lily powder suspension. The effect may be mediated by modulation of serotonergic system. To sum up, the ziziphi spinosae lily powder suspension could be a good drug candidate for combating depression. In the long history of human being, since both semen ziziphi spinosae and lily bulb are medicinal and edible materials, it is more simple and safety to introduce the combination as an alternative antidepressant to depressive patients. Certainly, the present study is preliminary research of the combination of semen ziziphi spinosae and lily bulb. Further investigations of the underlying mechanisms will be explored in next researches.

Abbreviations

5-HIAA:

5-hydroxyindoleacetic acid

5-HT:

serotonin

BW:

body weight

CUMS:

chronic unpredictable mild stress

FST:

forced swimming test

HPLC:

high-performance liquid chromatography

OFT:

open field test

Post-CUMS:

after chronic unpredictable mild stress

Pre-CUMS:

before chronic unpredictable mild stress

SCT:

sucrose consumption test

UPLC:

ultrahigh-performance liquid chromatography

References

  1. Zalsman G, Braun M, Arendt M, Grunebaum MF, Sher L, Burke AK, Brent DA, Chaudhury SR, Mann JJ, Oquendo MA. A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders. Bipolar Disord. 2006;8(5 Pt 2):558–65.

    Article  PubMed  Google Scholar 

  2. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav. 2005;82(1):200–6.

    Article  CAS  PubMed  Google Scholar 

  3. Hsu MC, Creedy D, Moyle W, Venturato L, Tsay SL, Ouyang WC. Use of Complementary and Alternative Medicine among adult patients for depression in Taiwan. J Affect Disord. 2008;111(2-3):360–5.

    Article  PubMed  Google Scholar 

  4. Dwyer AV, Whitten DL, Hawrelak JA. Herbal medicines, other than St. John's Wort, in the treatment of depression: a systematic review. Altern Med Rev. 2011;16(1):40–9.

    PubMed  Google Scholar 

  5. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21(12):841–60.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang M, Ning G, Shou C, Lu Y, Hong D, Zheng X. Inhibitory effect of jujuboside A on glutamate-mediated excitatory signal pathway in hippocampus. Planta Med. 2003;69(8):692–5.

    Article  CAS  PubMed  Google Scholar 

  7. Zhao J, Li SP, Yang FQ, Li P, Wang YT. Simultaneous determination of saponins and fatty acids in Ziziphus jujuba (Suanzaoren) by high performance liquid chromatography-evaporative light scattering detection and pressurized liquid extraction. J Chromatogr A. 2006;1108(2):188–94.

    Article  CAS  PubMed  Google Scholar 

  8. Zhang M, Zhang Y, Xie J. Simultaneous determination of jujuboside A, B and betulinic acid in semen Ziziphi spinosae by high performance liquid chromatography-evaporative light scattering detection. J Pharm Biomed Anal. 2008;48(5):1467–70.

    Article  CAS  PubMed  Google Scholar 

  9. Kayser S, Bewernick BH, Matusch A, Hurlemann R, Soehle M, Schlaepfer TE. Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychol Med. 2015;45(5):1073–92.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang Y, Qiao L, Song M, Wang L, Xie J, Feng H. Hplc-ESI-MS/MS analysis of the water-soluble extract from Ziziphi spinosae semen and its ameliorating effect of learning and memory performance in mice. Pharmacogn Mag. 2014;10(40):509–16.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Liu Z, Zhao X, Liu B, Liu AJ, Li H, Mao X, Wu B, Bi KS, Jia Y. Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Abeta 1-42. Eur J Pharmacol. 2014;738:206–13.

    Article  CAS  PubMed  Google Scholar 

  12. Chen CY, Chen YF, Tsai HY. What is the effective component in suanzaoren decoction for curing insomnia? Discovery by virtual screening and molecular dynamic simulation. J Biomol Struct Dyn. 2008;26(1):57–64.

    Article  CAS  PubMed  Google Scholar 

  13. Wang LE, Bai YJ, Shi XR, Cui XY, Cui SY, Zhang F, Zhang QY, Zhao YY, Zhang YH. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. Pharmacol Biochem Behav. 2008;90(3):399–403.

    Article  CAS  PubMed  Google Scholar 

  14. Feng ZY, Guo DW, Su S, Zhao H, Zheng XX. Sedative and anticonvulsant effect of jujuboside A. J Zhejiang Univ Med Sci. 2002;31(2):103–6.

    CAS  Google Scholar 

  15. Lu YJ, Zhou J, Zhang SM, Zhang HY, Zheng XX. Inhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive rat. J Zhejiang Univ Sci B. 2005;6(4):265–71.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wang C, You ZL, Xia Q, Xiong T, Xia Y, Yao DZ. Upregulation of Mark3 and Rpgrip1 mRNA expression by jujuboside A in mouse hippocampus. Acta Pharmacol Sin. 2007;28(3):334–8.

    Article  PubMed  Google Scholar 

  17. Liu J, Qiao W, Yang Y, Ren L, Sun Y, Wang S. Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression. J Ethnopharmacol. 2012;141(1):257–64.

    Article  PubMed  Google Scholar 

  18. Shou CH, Wang J, Zheng XX, Guo DW. Inhibitory effect of jujuboside A on penicillin sodium induced hyperactivity in rat hippocampal CA1 area in vitro. Acta Pharmacol Sin. 2001;22(11):986–90.

    CAS  PubMed  Google Scholar 

  19. Shao B, Zhou YL, Wang H, Lin YS. The role of calcitonin gene-related peptide in post-stroke depression in chronic mild stress-treated ischemic rats. Physiol Behav. 2015;139:224–30.

    Article  CAS  PubMed  Google Scholar 

  20. Okazaki Y, Chiji H, Kato N. Protective Effect of Dietary Lily Bulb on Dextran Sulfate Sodium-Induced Colitis in Rats Fed a High-Fat Diet. J Nutr Sci Vitaminol (Tokyo). 2016;62(3):206–12.

    Article  CAS  Google Scholar 

  21. Tang W, Munafo Jr JP, Palatini K, Esposito D, Huang MT, Komarnytsky S, Ho CT, Gianfagna TJ. Hepatoprotective Activity of Easter Lily (Lilium longiflorum Thunb.) Bulb Extracts. J Agric Food Chem. 2015;63(44):9722–8.

    Article  CAS  PubMed  Google Scholar 

  22. Zhang ZB. Studies on the title of syndromes in Ben cao gang mu (Compendium of Materia Medica). Zhonghua Yi Shi Za Zhi. 2012;42(6):323–7.

    PubMed  Google Scholar 

  23. Lin RD, Hou WC, Yen KY, Lee MH. Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines. Phytomedicine. 2003;10(8):650–6.

    Article  CAS  PubMed  Google Scholar 

  24. Chen ML, Gao J, He XR, Chen Q. Involvement of the cerebral monoamine neurotransmitters system in antidepressant-like effects of a chinese herbal decoction, baihe dihuang tang, in mice model. Evid Based Complement Alternat Med. 2012;2012:419257.

    PubMed  PubMed Central  Google Scholar 

  25. Doron R, Lotan D, Rak-Rabl A, Raskin-Ramot A, Lavi K, Rehavi M. Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life Sci. 2012;90(25-26):995–1000.

    Article  CAS  PubMed  Google Scholar 

  26. Doron R, Lotan D, Einat N, Yaffe R, Winer A, Marom I, Meron G, Kately N, Rehavi M. A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life Sci. 2014;94(2):151–7.

    Article  CAS  PubMed  Google Scholar 

  27. Wu LM, Han H, Wang QN, Hou HL, Tong H, Yan XB, Zhou JN. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology. 2007;32(12):2500–10.

    Article  CAS  PubMed  Google Scholar 

  28. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47(4):379–91.

    Article  CAS  PubMed  Google Scholar 

  29. Papp M, Willner P, Muscat R. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl). 1991;104(2):255–9.

    Article  CAS  Google Scholar 

  30. Aboul-Fotouh S. Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters. Psychopharmacology. 2015;232(6):1095–105.

    Article  CAS  PubMed  Google Scholar 

  31. Xu J, Xu H, Liu Y, He H, Li G. Vanillin-induced amelioration of depression-like behaviors in rats by modulating monoamine neurotransmitters in the brain. Psychiatry Res. 2015;225(3):509–14.

    Article  CAS  PubMed  Google Scholar 

  32. Schmidt D, Roznoski M, Ebert MH. Liquid Chromatographic Analysis of Monoamine Neurotransmitters and Metabolites in Cerebrospinal Fluid and Brain Tissue Using Reductive Electrochemical Detection. Biomed Chromatogr. 1990;4(5):215–20.

    Article  CAS  PubMed  Google Scholar 

  33. Croom KF, Perry CM, Plosker GL. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs. 2009;23(5):427–52.

    Article  CAS  PubMed  Google Scholar 

  34. Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2(5):343–51.

    Article  CAS  PubMed  Google Scholar 

  35. Butler L, Pilkington K. Chinese herbal medicine and depression: the research evidence. Evid Based Complement Alternat Med. 2013;2013:739716.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Linde K. St. John's wort for depression--development of a Cochrane review from 1993 to 1996. Z Evid Fortbild Qual Gesundhwes. 2008;102(8):487–92.

    Article  PubMed  Google Scholar 

  37. Cao JX, Zhang QY, Cui SY, Cui XY, Zhang J, Zhang YH, Bai YJ, Zhao YY. Hypnotic effect of jujubosides from Semen Ziziphi Spinosae. J Ethnopharmacol. 2010;130(1):163–6.

    Article  CAS  PubMed  Google Scholar 

  38. Ravid R. The uniqueness of biobanks for neurological and psychiatric diseases: potentials and pitfalls. Pathobiology. 2014;81(5-6):237–44.

    Article  CAS  PubMed  Google Scholar 

  39. Wang Y, Fan R, Huang X. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. J Ethnopharmacol. 2012;141(2):571–7.

    Article  PubMed  Google Scholar 

  40. Zhang Y, Han M, Liu Z, Wang J, He Q, Liu J. Chinese herbal formula xiao yao san for treatment of depression: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2012;2012:931636.

    PubMed  Google Scholar 

  41. Qin F, Wu XA, Tang Y, Huang Q, Zhang ZJ, Yuan JH. Meta-analysis of randomized controlled trials to assess the effectiveness and safety of Free and Easy Wanderer Plus, a polyherbal preparation for depressive disorders. J Psychiatr Res. 2011;45(11):1518–24.

    Article  PubMed  Google Scholar 

  42. Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. J Recept Signal Transduct Res. 1999;19(1-4):59–74.

    Article  CAS  PubMed  Google Scholar 

  43. Mineur YS, Prasol DJ, Belzung C, Crusio WE. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet. 2003;33(5):513–9.

    Article  PubMed  Google Scholar 

  44. Dalvi A, Lucki I. Murine models of depression. Psychopharmacology (Berl). 1999;147(1):14–6.

    Article  CAS  Google Scholar 

  45. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23(5):238–45.

    Article  CAS  PubMed  Google Scholar 

  46. Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res. 1996;73(1-2):43–6.

    Article  CAS  PubMed  Google Scholar 

  47. Muscat R, Sampson D, Willner P. Dopaminergic mechanism of imipramine action in an animal model of depression. Biol Psychiatry. 1990;28(3):223–30.

    Article  CAS  PubMed  Google Scholar 

  48. Pan J, Lei X, Wang J, Huang S, Wang Y, Zhang Y, Chen W, Li D, Zheng J, Cui H, et al. Effects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depression. BMC Complement Alternat Med. 2015;15:291.

    Article  Google Scholar 

  49. Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol. 2001;16(1):9–21.

    Article  CAS  PubMed  Google Scholar 

  50. Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal Medicine for Anxiety, Depression and Insomnia. Curr Neuropharmacol. 2015;13(4):481–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113(504):1237–64.

    Article  CAS  PubMed  Google Scholar 

  52. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965;122(5):509–22.

    Article  CAS  PubMed  Google Scholar 

  53. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54(1):129–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank veteran doctor of traditional Chinese medicine, Bingchu Zhang, for his valuable inspiration and comments.

Funding

This research was supported by the National Natural Science Foundation of China, China (81000589). The funding bodies had no role in the design, collection, analysis and interpretation of the data, or in the writing of the manuscript or in the decision to submit the manuscript for publication.

Availability of data and materials

The materials and data of study are available to other researchers upon request.

Authors’ contributions

MH and XL established the depression animal model and evaluated the depression-like behaviors of animals. YW and RW performed UPLC and HPLC. YW and JX analyzed the data and wrote the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interest.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The present study was performed in compliance with the Animal Scientific Procedures Act of 1986 and received approval of laboratory animal ethics committee of Anhui Medical University (license number: LLSC2013006).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

  1. The first clinical college, Anhui Medical University, Hefei, 230032, People’s Republic of China

    Yifang Wang, Mei Huang, Xinyi Lu & Runze Wei

  2. High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, People’s Republic of China

    Jinyong Xu

  3. University of Science and Technology of China, Hefei, 230022, People’s Republic of China

    Jinyong Xu

  4. Department of Anatomy, Anhui Medical University, Hefei, 230032, People’s Republic of China

    Jinyong Xu

Authors
  1. Yifang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinyi Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Runze Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jinyong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jinyong Xu.

Additional files

Additional file 1: Figure S1.

Chromatograms of 5-HT under optimal conditions. A: Chromatogram of the 5-HT standard. B: Chromatogram of the serum sample. The chromatographic separation for 5-HT was carried out using the mobile phase consisting of 0.1 mol/l KH2PO4 and methanol (80:20, V/V; pH=4.3), at a flow rate of 0.3 ml/min. The mobile phase was filtered with 0.22um filter membrane and degassed in an ultrasonic bath before measurement. The injection volume was 5 μl. The excitation wavelength was 278 nm and the emission wavelength was 338 nm. (TIF 441 kb)

Additional file 2: Figure S2.

Chromatograms of 5-HIAA under optimal conditions. A: Chromatogram of the 5-HIAA standard. B: Chromatogram of the brain sample. The chromatographic separation for 5-HIAA was carried out using 2000 ml mobile phase consisting of 20.7 g NaH2PO4, 0.735 g Octanesulfonic Acid Sodium, 200 ml acetonitrile, 200ul triethylamine, 25umol EDTA at a flow rate of 1 ml/min (pH = 3.8). The mobile phase was filtered with 0.22um filter membrane and was degassed on line before measurement. The injection volume was 20 μl. (TIF 263 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Huang, M., Lu, X. et al. Ziziphi spinosae lily powder suspension in the treatment of depression-like behaviors in rats. BMC Complement Altern Med 17, 238 (2017). https://doi.org/10.1186/s12906-017-1749-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-017-1749-5

Keywords

  • Semen ziziphi spinosae
  • Lily bulb
  • Major depressive disorder
  • Antidepressant
  • 5-HT
  • 5-HIAA

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us